Drug Companies Update Apr 2008
Mergers, acquisitions & Joint Ventures
- Abraxis BioScience has acquired Shimoda Biotech.
- Advanced Targeting Systems is now called Advanced Pain Therapeutics.
- Microbia is now known as Ironwood Pharmaceuticals.
- Neurochem has changed its name to Bellus Health.
New Companies
- Arno Therapeutics is developing innovative anticancers.
- Airmid is a virtual pharmaceutical company focused on the development and commercialization of treatments for autoimmune disorders, concerned with the Kv1.3 potassium channel.
- AKL International develops drugs derived from botanical sources.
- Bexicon Pharmaceuticals is developing treatments for cancer, using a platform technology licensed from Cincinnati Children's hospital.
- Bioalvo is a Portugese biotechnology company aimed at developing therapies for CNS and neurodegenerative disorders.
- Carbylan develops and markets medical devices and device/drug combinations based on chemically-engineered polymers of hyaluronic acid.
- DermaGen is a Swedish outfit involved in the development of novel antimicrobial peptides.
- Epidyme is a pharmaceutical company engaged in the development of immunotherapies.
- Haemacure Corporation is using its plasma protein extraction technology to develop next-generation haematological products.
- Ineos Healthcare is developing therapies for GI and renal diseases
- Kalos Therapeutics is a biopharmaceutical company that in-licenses, develops and commercializes anticancer agents. It specializes in developing non-toxic endogenous peptides.
- Biopharmaceutical company Kinexum Metabolics is investigating metabolic and endocrine therapies.
- Lee's Pharmaceutical is a Hong Kong listed biopharmaceutical company focused on several therapeutic areas.
- Neureva focuses on treatments for neurological diseases, in particular spinal cord injury, brain trauma and stroke.
- NeuroGeneration is developing stem cells for the treatment of Alzheimer’s and Parkinson’s diseases, as well as connective tissue replacement.
- Nostrum Pharmaceuticals develops and commercializes products using novel drug delivery systems for generic and branded pharmaceuticals.
- Nuevolution is using its chemetics technology to discover new therapies in the areas of hypertension and thrombosis.
- Nidus Laboratories is developing cyclic peptides and organic molecules which modulate protein-protein interactions.
- Oncolin Therapeutics is focused on the development of biopharmaceutical anticancers.
- Quantum Pharmaceuticals is a drug discovery company based in Russia.
- Stelic Institute is primarily concerned with developing stem cells for currently untreatable diseases.
- Syndexa Pharmaceuticals develops small molecules for the treatment of metabolic disorders.
- Transdel Pharmceuticals is engaged in the development and commercialization of non-invasive topically delivered medications.
- Vivalis is using its EBx platform to develop embryonic stem cells for the treatment of viral infection.
- VM Discovery is developing small-molecules in various therapeutic areas.
